Estrogen receptor-dependent genomic expression profiles in breast cancer cells in response to fatty acids

Journal of Carcinogenesis

Volumn 8, Issue , 2009, Pages

  Alquobaili, Faizeh ^a   Miller, Stacy Ann ^a   Muhie, Seid ^a   Day, Agnes ^b   Jett, Marti ^a   Hammamieh, Rasha ^a,c  

^a DAMASCUS UNIVERSITY   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c HOWARD UNIVERSITY   (United States)

Author keywords

breast cancer; Estrogen receptor; fatty acids; microarray; omega 3; omega 6

Indexed keywords

AGRIN; ARACHIDONIC ACID; ARGININE; BRUTON TYROSINE KINASE; CASPASE 4; CELL CYCLE PROTEIN; CLUSTERIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 2 INHIBITOR; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DESMOGLEIN 1; ESTROGEN RECEPTOR; FRAGILE X MENTAL RETARDATION PROTEIN; HEPATOMA DERIVED GROWTH FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; LAMIN A; LAMIN C; NUCLEOPHOSMIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLECKSTRIN; POLYADENYLIC ACID BINDING PROTEIN; RIBOSOME PROTEIN; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; UNINDEXED DRUG;

ANALYSIS OF VARIANCE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CORRELATION ANALYSIS; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; XENOPUS LAEVIS;

EID: 77956572437     PISSN: 09746773     EISSN: 14773163     Source Type: Journal    
DOI: 10.4103/1477-3163.59539     Document Type: Article

References (30)

1. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004;96:218-28.
2. Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S. Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 2003;12:1053-60.
3. Olsen A, Tjnneland A, Thomsen BL, Loft S, Stripp C, Overvad K, et al. Fruits and vegetables intake differentially affects estrogen receptor negative and positive breast cancer incidence rates. J Nutr 2003;133:2342-7.
4. Cho E, Chen WY, Hunter DJ, Stampfer MJ, Colditz GA, Hankinson SE, et al. Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 2006;166:2253-9.
5. Jakovljevic J, Touillaud MS, Bondy ML, Singletary SE, Pillow PC, Chang S. Dietary intake of selected fatty acids, cholesterol and carotenoids and estrogen receptor status in premenopausal breast cancer patients. Breast Cancer Res Treat 2002;75:5-14.
6. Gruvberger S, Ringnr M, Chen Y, Panavally S, Saal LH, Borg A, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 2001;61:5979-84.
7. Hammamieh R, Chakraborty N, Miller SA, Waddy E, Barmada M, Das R, et al. Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat 2007;101:7-16.
8. Hammamieh R, Ribot WJ, Abshire TG, Jett M, Ezzell J. Activity of the Bacillus anthracis 20 kDa protective antigen component. BMC Infect Dis 2008;8:124.
9. Al-Shahrour F, Minguez P, Trraga J, Medina I, Alloza E, Montaner D, et al. FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments. Nucleic Acids Res 2007;35:W91-6.
10. Al-Shahrour F, Minguez P, Trraga J, Montaner D, Alloza E, Vaquerizas JM, et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res 2006;34:W472-6.
11. Hammamieh R, Chakraborty N, Wang Y, Laing M, Liu Z, Mulligan J, et al. GeneCite: A Stand-alone Open Source Tool for High-Throughput Literature and Pathway Mining. OMICS 2007;11:143-51.
12. Fung TT, Hu FB, McCullough ML, Newby PK, Willett WC, Holmes MD. Diet quality is associated with the risk of estrogen receptor-negative breast cancer in postmenopausal women. J Nutr 2006;136:466-72.
13. Suzuki R, Ye W, Rylander-Rudqvist T, Saji S, Colditz GA, Wolk A. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst 2005;97:1601-8.
14. McCann SE, Kulkarni S, Trevisan M, Vito D, Nie J, Edge SB, et al. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status. Breast Cancer Res Treat 2006;99:309-11.
15. Bougnoux P, Maillard V, Ferrari P, Jourdan ML, Chajs V. n-3 fatty acids and breast cancer. IARC Sci Publ 2002;156:337-41.
16. Chajs V, Sattler W, Stranzl A, Kostner GM. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res Treat 1995;34:199-212.
17. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, et al. Wnt/beta-catenin and estrogen signaling converge in vivo. J Biol Chem 2004;279:40255-8.
18. Hsu HH, Cheng SF, Chen LM, Liu JY, Chu CH, Weng YJ, et al. Over-expressed estrogen receptor-alpha up-regulates hTNF-alpha gene expression and down-regulates beta-catenin signaling activity to induce the apoptosis and inhibit proliferation of LoVo colon cancer cells. Mol Cell Biochem 2006;289:101-9.
19. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 2007;1773:1263-84.
20. Boucher MJ, Morisset J, Vachon PH, Reed JC, Lain J, Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 2000;79:355-69.
21. Schmitz KJ, Wohlschlaeger J, Lang H, Sotiropoulos GC, Malago M, Steveling K, et al. Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection. J Hepatol 2008;48:83-90.
22. Siddiqa A, Long LM, Li L, Marciniak RA, Kazhdan I. Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways. BMC Cancer 2008;8:129.
23. Improta-Brears T, Whorton AR, Codazzi F, York JD, Meyer T, McDonnell DP. Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci U S A 1999;96:4686-91.
24. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 2007;27:1516-30.
25. Lanzino M, Morelli C, Garofalo C, Panno ML, Mauro L, And S, et al. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr Cancer Drug Targets 2008;8:597-610.
26. Eng-Wong J, Perkins SN, Bondy M, Li D, Eva Singletary S, Nez N, et al. Premenopausal breast cancer: estrogen receptor status and insulin-like growth factor-I (IGF-I), insulin-like growth factor binding protein-3 (IGFBP-3), and leptin. Breast J 2009;15:426-8.
27. Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology 2007;148:4091-101.
28. Morelli C, Garofalo C, Bartucci M, Surmacz E. Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. Oncogene 2003;22:4007-16.
29. Keller H, Givel F, Perroud M, Wahli W. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol 1995;9:794-804.
30. Wang X, Kilgore MW. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol 2002;194:123-33.